News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
604,835 Results
Type
Article (46292)
Company Profile (582)
Press Release (557961)
Multimedia
Podcasts (32)
Webinars (8)
Section
Business (163308)
Career Advice (2382)
Deals (30998)
Drug Delivery (108)
Drug Development (71584)
Employer Resources (138)
FDA (17017)
Job Trends (13495)
News (292869)
Policy (33312)
Tag
Academia (2647)
Academic (1)
Accelerated approval (5)
Adcomms (22)
Allergies (85)
Alliances (44897)
ALS (96)
Alzheimer's disease (1321)
Antibody-drug conjugate (ADC) (127)
Approvals (17012)
Artificial intelligence (283)
Autoimmune disease (23)
Automation (16)
Bankruptcy (305)
Best Places to Work (11201)
BIOSECURE Act (21)
Biosimilars (116)
Biotechnology (403)
Bladder cancer (76)
Brain cancer (27)
Breast cancer (280)
Cancer (2193)
Cardiovascular disease (178)
Career advice (1997)
Career pathing (28)
CAR-T (148)
Cell therapy (416)
Cervical cancer (21)
Clinical research (58456)
Collaboration (809)
Compensation (389)
Complete response letters (21)
COVID-19 (2700)
CRISPR (43)
C-suite (210)
Cystic fibrosis (94)
Data (2192)
Decentralized trials (2)
Denatured (5)
Depression (47)
Diabetes (271)
Diagnostics (6263)
Digital health (20)
Diversity (5)
Diversity, equity & inclusion (34)
Drug discovery (124)
Drug pricing (113)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (65337)
Editorial (43)
Employer branding (17)
Employer resources (124)
Events (80445)
Executive appointments (626)
FDA (18419)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (9)
Funding (739)
Gene editing (108)
Generative AI (27)
Gene therapy (301)
GLP-1 (686)
Government (4682)
Grass and pollen (4)
Guidances (149)
Healthcare (17657)
Huntington's disease (18)
IgA nephropathy (27)
Immunology and inflammation (98)
Indications (27)
Infectious disease (2852)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (102)
Interviews (446)
IPO (15121)
IRA (40)
Job creations (2800)
Job search strategy (1663)
Kidney cancer (9)
Labor market (36)
Layoffs (395)
Leadership (21)
Legal (7615)
Liver cancer (75)
Lung cancer (300)
Lymphoma (143)
Machine learning (9)
Management (47)
Manufacturing (335)
MASH (65)
Medical device (13233)
Medtech (13238)
Mergers & acquisitions (16445)
Metabolic disorders (656)
Multiple sclerosis (81)
NASH (10)
Neurodegenerative disease (90)
Neuropsychiatric disorders (21)
Neuroscience (1846)
NextGen: Class of 2025 (6401)
Non-profit (4283)
Now hiring (12)
Obesity (335)
Opinion (220)
Ovarian cancer (75)
Pain (99)
Pancreatic cancer (83)
Parkinson's disease (140)
Partnered (19)
Patents (249)
Patient recruitment (111)
Peanut (49)
People (43950)
Pharmaceutical (117)
Pharmacy benefit managers (21)
Phase I (17547)
Phase II (25384)
Phase III (20166)
Pipeline (1293)
Policy (150)
Postmarket research (2502)
Preclinical (7245)
Press Release (70)
Prostate cancer (106)
Psychedelics (31)
Radiopharmaceuticals (239)
Rare diseases (368)
Real estate (4953)
Recruiting (57)
Regulatory (23233)
Reports (37)
Research institute (2344)
Resumes & cover letters (396)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (65)
Series A (124)
Series B (84)
Service/supplier (23)
Sickle cell disease (50)
Special edition (17)
Spinal muscular atrophy (147)
Sponsored (32)
Startups (3191)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (51)
The Weekly (27)
Vaccines (744)
Venture capitalists (30)
Weight loss (214)
Women's health (25)
Worklife (16)
Date
Today (26)
Last 7 days (855)
Last 30 days (2772)
Last 365 days (30651)
2025 (10996)
2024 (33129)
2023 (37239)
2022 (48160)
2021 (52138)
2020 (51147)
2019 (43968)
2018 (33760)
2017 (30922)
2016 (29370)
2015 (33631)
2014 (25226)
2013 (20680)
2012 (22444)
2011 (22736)
2010 (20245)
Location
Africa (798)
Alabama (48)
Alaska (7)
Arizona (159)
Arkansas (13)
Asia (37082)
Australia (6551)
California (5832)
Canada (1858)
China (494)
Colorado (258)
Connecticut (274)
Delaware (150)
Europe (83405)
Florida (898)
Georgia (213)
Hawaii (1)
Idaho (50)
Illinois (515)
India (27)
Indiana (294)
Iowa (12)
Japan (166)
Kansas (96)
Kentucky (17)
Louisiana (13)
Maine (61)
Maryland (874)
Massachusetts (4269)
Michigan (210)
Minnesota (350)
Mississippi (2)
Missouri (87)
Montana (25)
Nebraska (20)
Nevada (58)
New Hampshire (67)
New Jersey (1745)
New Mexico (28)
New York (1677)
North Carolina (963)
North Dakota (8)
Northern California (2456)
Ohio (198)
Oklahoma (10)
Oregon (37)
Pennsylvania (1213)
Puerto Rico (11)
Rhode Island (31)
South America (1069)
South Carolina (24)
South Dakota (1)
Southern California (2213)
Tennessee (97)
Texas (876)
United States (22021)
Utah (175)
Virginia (160)
Washington D.C. (63)
Washington State (523)
West Virginia (3)
Wisconsin (65)
604,835 Results for "xoma us llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
April 2, 2025
·
6 min read
Press Releases
ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts
March 5, 2025
·
6 min read
Business
XOMA Declares Quarterly Preferred Stock Dividends - June 20, 2024
XOMA Corporation announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferred Stock.
June 20, 2024
·
3 min read
Press Releases
XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
1 min read
Press Releases
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
National Distributor to Sell Cold Sore Prevention Device Through National Ecommerce Sales Through Direct to Consumer Marketing Efforts
March 13, 2025
·
4 min read
Deals
XOMA Declares Quarterly Preferred Stock Dividends - March 21, 2024
XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferred Stock.
March 21, 2024
·
3 min read
Biotech Bay
XOMA Corporation Announces Closing of Tender Offer
XOMA Corporation announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Kinnate Biopharma Inc.
April 3, 2024
·
5 min read
Biotech Bay
XOMA to Present at Upcoming Investor Conferences in March
XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following March 2024 investor conferences.
February 28, 2024
·
1 min read
Business
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
XOMA Corporation, the biotech royalty aggregator, reported its first quarter 2024 financial results and highlighted recent activities.
May 9, 2024
·
14 min read
Press Releases
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
January 14, 2025
·
7 min read
1 of 60,484
Next
